# Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non–Small-Cell Lung Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/five-year-outcomes-from-the-randomized-phase-iii-trials-checkmate-017-and-057/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Hossein Borghaei,Scott Gettinger,Everett E. Vokes,Laura Q.M. Chow,Marco Angelo Burgio,Javier de Castro,Adam Płużański,Óscar Arrieta,Osvaldo Arén Frontera,Rita Chiari,Charles Butts,Joanna Wójcik-Tomaszewska,Bruno Coudert,Marina Chiara Garassino,Neal Ready,Enriqueta Felip,M. Alonso Garcìa,David Waterhouse,Manuel Dómine,Fabrice Barlési,Scott Antonia,M Wohlleber,David E. Gerber,Grzegorz Czyżewicz,David R. Spigel,Lucio Crinò,Wilfried Eberhardt,Ang Li,S. Marimuthu,Julie R. Brahmer |
| Citations | 672 |
| DOI | 10.1200/jco.20.01605 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1200/jco.20.01605 |
| OpenAlex ID | https://openalex.org/W3120933346 |
| PMID | 33449799 |
| Type | article |
| Year | 2021 |

## Paper authors

- [David R. Spigel](https://scholariq.org/researchers/david-r-spigel/)
- [Enriqueta Felip](https://scholariq.org/researchers/enriqueta-felip/)
- [Marina Chiara Garassino](https://scholariq.org/researchers/marina-chiara-garassino/)
- [Julie R. Brahmer](https://scholariq.org/researchers/julie-r-brahmer/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.